Bio-rad Laboratories, Inc. logo

BIO

Bio-rad Laboratories, Inc.

$338.77

Earnings Summary

Revenue
$649.73Mn
Net Profits
$653.17Mn
Net Profit Margins
100.53%

Highlights

Revenue:

Bio-rad Laboratories, Inc.’s revenue jumped 2.79% since last year same period to $649.73Mn in the Q3 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 1.76% jump in its revenue since last 3-months.

Net Profits:

Bio-rad Laboratories, Inc.’s net profit jumped 514.71% since last year same period to $653.17Mn in the Q3 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 130.16% jump in its net profits since last 3-months.

Net Profit Margins:

Bio-rad Laboratories, Inc.’s net profit margin jumped 498.05% since last year same period to 100.53% in the Q3 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 129.64% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Bio-rad Laboratories, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
1.16
EPS Estimate Current Year
1.16

Highlights

EPS Estimate Current Quarter:

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.16 - a -42.29% fall from last quarter’s estimates.

EPS Estimate Current Year:

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 1.16.

Key Ratios

Key ratios of the Bio-rad Laboratories, Inc. post its Q3 2024 earnings

Earning Per Share (EPS)
2.01

Highlights

Earning Per Share (EPS):

Bio-rad Laboratories, Inc.’s earning per share (EPS) fell -13.73% since last year same period to 2.01 in the Q3 2024. This indicates that the Bio-rad Laboratories, Inc. has generated -13.73% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-08-02
2.01
3.11
54.73%
2024-05-08
2.15
2.29
6.51%
2024-10-31
1.16
2.01
73.28%

Discover More Earning Stocks in Health Technology Sector